United Therapeutics Corporation
UTHR
$307.24
$1.850.61%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -1.74% | 4.76% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -1.74% | 4.76% | |||
Cost of Revenue | -8.66% | 6.81% | |||
Gross Profit | -0.87% | 4.50% | |||
SG&A Expenses | 6.62% | -13.23% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 9.77% | -13.75% | |||
Operating Income | -11.34% | 27.60% | |||
Income Before Tax | 2.03% | 9.37% | |||
Income Tax Expenses | 19.75% | 2.98% | |||
Earnings from Continuing Operations | -2.52% | 11.15% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -2.52% | 11.15% | |||
EBIT | -11.34% | 27.60% | |||
EBITDA | -10.70% | 26.20% | |||
EPS Basic | -2.74% | 10.65% | |||
Normalized Basic EPS | -10.85% | 26.11% | |||
EPS Diluted | -3.22% | 9.23% | |||
Normalized Diluted EPS | -11.20% | 24.32% | |||
Average Basic Shares Outstanding | 0.22% | 0.45% | |||
Average Diluted Shares Outstanding | 0.62% | 1.89% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |